Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.56 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.56 |
| ▸ | VKORC1 | Q9BQB6 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL31053401 | 0.92 | NQO1 (0.53) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL15842922 | 0.85 | KDM4E (0.54) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL6589409 | 0.84 | NQO1 (0.75) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL21645800 | 0.84 | GAA (0.62) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL21645801 | 0.84 | GAA (0.62) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL27687468 | 0.81 | NQO1 (0.53) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL8083350 | 0.80 | CA12 (0.53) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL13506406 | 0.80 | CA12 (0.53) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL4530526 | 0.78 | SRC (0.52) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 | |
| SCHEMBL1568301 | 0.77 | NQO1 (0.66) | NQO1ALDH1A1CYP3A4CYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115819468-A | Organic metal complex, image storage material based on organic metal complex, and preparation and application of image storage material | 华中科技大学 | 2023-03-21 | — | — | CN | claimed |
| CN-111533842-B | Preparation method of polymer/perovskite composite material | 华中科技大学 | 2021-07-27 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| EP-4680677-A1 | BENZOTHIENOPYRROLE CYANINE DYES | Beckman Coulter, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20250383357-A1 | NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES | BECKMAN COULTER INC (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4547759-A2 | NOVEL FLUORESCENT DYES AND POLYMERS FROM DIHYDROPHENANTHRENE DERIVATIVES | Beckman Coulter, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025064842-A1 | DIHYDROPHENANTHRENE (DHP) BRIDGED DYES FOR USE IN FLOW CYTOMETRY | BECKMAN COULTER, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-119630747-A | Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives | 贝克曼库尔特有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240400893-A1 | WATER-SOLUBLE TETRAHYDROPYRENE BASED FLUORESCENT POLYMERS | BECKMAN COULTER, INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2024196805-A1 | BENZOTHIENOPYRROLE CYANINE DYES | BECKMAN COULTER, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20240270971-A1 | UV-ABSORBING POLYMERS, COMPOSITIONS AND USES THEREOF | BECKMAN COULTER, INC. | 2024-08-15 | — | — | US | disclosed |
| EP-2167963-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | Ventana Medical Systems, Inc. (US) | 2010-03-31 | — | — | EP | disclosed |
| EP-2078197-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008153744-A2 | POLYMERIC CARRIERS FOR IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | VENTANA MEDICAL SYSTEMS, INC. | 2008-12-11 | — | — | US | disclosed |
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | VENTANA MEDICAL SYSTEMS, INC. | 2008-10-30 | — | — | US | disclosed |
| WO-2008063378-A9 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008063378-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| US-20030152634-A1 | Extended release particle dispersion | LABORATORIOS FARMACEUTICOS ROVI S.A. (ES) | 2003-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268462-A1 | Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits | HRH4, CRBN, NCDN | NQO1 2535/4885ALDH1A1 2096/4885CYP3A4 71/4885 |
| US-20080305497-A1 | Polymeric carriers for immunohistochemistry and in situ hybridization | FCGR2A, CD68, CA14 | NQO1 594/4885ALDH1A1 180/4885CYP3A4 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.